Moreover, ATPP-mediated sensitization of tumor cells expressing the cell surface proteoglycan CD138 (Syndecan-1) showed similar efficacy (Figure 3D), highlighting the transferability of the ATPP approach to other cancer targets. Here, SDC1 is linked to neoplasm.